DJIA 17,683.58 -46.53 -0.26%
NASDAQ 4,991.94 -17.27 -0.34%
S&P 500 2,068.76 -8.02 -0.39%
market minute promo


company name or ticker

US Stock Futures Drop Ahead Of Economic Data

Strensiq Receives Marketing Approval in Japan for Treatment of Patients with Hypophosphatasia

The Competitive Advantage of the Best Biotech Stocks

The 4-letter word that differentiates the best biotechs: M-O-A-T

Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal, BioMarin/Sarepta DMD Drugs Progress - Ana

Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal, BioMarin/Sarepta DMD Drugs Progress - Analyst Blog

10 Worst Health Care Stocks in the S&P 500

Andreas Halvorsen Increases Stake in Esperion Therapeutics

Alexion's Strensiq and Kanuma Get Positive CHMP Opinions - Analyst Blog

Is it Time for this Biotech to Change Management?

With Aegerion Pharmaceuticals down 500% from its all-time high, the current CEO's tenure is trying investors' patience.

Short Sellers Get More Selective on Big Biotech

Bernstein: Alexion Pharma An Outperform, Worth $267/Share

See More Articles...